EQS News EQS News
News
Feed
Events
Feed
News
+ Events
Feed

Recently viewed news

Recently viewed Companies

Search Results of news

Show all

Search Results of Companies

Show all

Search Results of events

Show all
News Feed My Watchlists News Latest Reports Latest Research My favorite News
Events Feed Past Events Upcoming Webcasts Past Webcasts My favorite Events
Log in/Register
en

Recently viewed news

Recently viewed Companies

Search Results of news

Show all

Search Results of Companies

Show all

Search Results of events

Show all
  • ISIN DE000A1EWVY8
  • Country Deutschland

Total Voting Rights | 11 November 2024 14:03

Formycon AG
Formycon AG: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Formycon AG / Total Voting Rights Announcement
Formycon AG: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
11.11.2024 / 14:03 CET/CEST
Total Voting Rights Announcement transmitted by EQS News – a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

Publication of new total number of voting rights according to Sec. 41 WpHG

1. Details of issuer
Formycon AG
Fraunhoferstraße 15
82152 Planegg-Martinsried
Germany

2. Type of capital measure or other measure
  Type of capital measure or other measure Date of status / date of effect
  Conditional capital increase (Sec. 41 para. 2 WpHG)
X Other (capital) measure (Sec. 41 para. 1 WpHG) 11 Nov 2024

3. New total number of voting rights:
17.664.427
number of multiple voting rights thereof: 0


11.11.2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com
Language: English
Company: Formycon AG
Fraunhoferstraße 15
82152 Planegg-Martinsried
Germany
Internet: www.formycon.com

 
End of News EQS News Service

show this

Latest News

News Functions

Additional Functions

19 November 2024

06:30 Corporate

Formycon AG

Corporate

Formycon invites to earnings call on the nine-month results 2024 and announces participation in international investor conferences

18 November 2024

06:30 Corporate

Formycon AG

Corporate

Formycon receives positive CHMP opinion for FYB203 (aflibercept), a biosimilar candidate to Eylea® under the tradenames AHZANTIVE® and Baiama®

15 November 2024

18:18 Ad-hoc

Formycon AG

Ad-hoc

Aflibercept-Biosimilar FYB203 / AHZANTIVE®/ Baiama® receives positive CHMP Opinion from EMA

13 November 2024

13:57 Voting Rights Announcements DE

Formycon AG

Voting Rights Announcements
DE

 
13:57 Voting Rights Announcements DE

Formycon AG

Voting Rights Announcements
DE

 
More News

Latest Reports

News Functions

Additional Functions

22 October 2024

Quarterly Report PDF

Formycon AG

Quarterly Report
PDF

Half-yearly financial statements 2024

29 April 2024

Annual Report PDF

Formycon AG

Annual Report
PDF

Annual financial statements 2023

30 August 2023

Quarterly Report PDF

Formycon AG

Quarterly Report
PDF

Half-yearly financial statements 2023
More Reports

Upcoming Events

Event Functions

Additional Functions

25

Nov 24

Formycon AG

Analysts’ Conference

Frankfurt am Main

28

Nov 24

Formycon AG

Press Release – quarterly statement (call-date Q3)

Martinsried/Planegg
More Events

Webcasts

No Webcasts found
Language (EN)
Legal Notice Data Protection